Back

Biolimus-coated balloon or sirolimus-coated balloon vs paclitaxel-coated balloon for in-stent restenosis: a systematic review and meta-analysis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Choosing the optimal devices in percutaneous coronary intervention Percutaneous Coronary Intervention (PCI) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Ms Caterina Lecchi

(Switzerland)

7 More presentations in this session

Presentation thumbnail
Outcomes in functionally guided DCB versus stent PCI: a propensity-matched analysis
Professor A. Leone (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes of drug coated balloons versus drug eluting stents in patients with small vessel coronary artery disease
Assistant Professor M. Arab (Zagazig, EG)
Abstract Slides Video
Presentation thumbnail
Sex-specific outcomes following percutaneous coronary interventions with drug-coated balloons
Miss L. Stutz (Luzern, CH)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes of stent-less percutaneous coronary intervention with intravascular lithotripsy and drug-coated balloon for severely calcified de novo coronary lesions.
Doctor T. Misawa (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Meta-analysis of randomized trials: DEB versus DES in patients with de novo coronary artery disease
Doctor H. Rai (Dublin 7, IE)
Abstract Slides Video

Access the full session

Session thumbnail
Choosing the optimal devices in percutaneous coronary intervention

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Comparative outcomes of drug-coated balloon angioplasty versus second-generation drug-eluting stent for in-stent restenosis: a real-world data analysis
thumbnail
Congress Presentation
Percutaneous coronary intervention of in-stent restenosis: A three-arm analysis from SWEDEHEART
thumbnail
Congress Presentation
Safety and efficacy of low-dose versus high-dose paclitaxel-coated balloons in patients with femoropopliteal lesions: an updated and meta-analysis.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources